Robert E Claypoole sold $262K of Bioventus (BVS)

Executed Jan 13 2025, disclosed Jan 14 2025, 1 day later.

Value, as filed

$262K

28,786 sh × $9.10

Executed

Jan 13 2025

the trade date, as filed

Disclosed

Jan 14 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RC Robert E Claypoole President and CEO profile →

Robert E Claypoole (President and CEO) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in BVS. The largest single filing was $262K of BVS (28,786 sh × $9.10, as filed), executed Jan 13 2025.

The name

BVS BVS BVS · 4 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→